Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Sarah E. Sinnett"'
Autor:
Sarah E. Sinnett, Ralph D. Hector, Kamal K.E. Gadalla, Clifford Heindel, Daphne Chen, Violeta Zaric, Mark E.S. Bailey, Stuart R. Cobb, Steven J. Gray
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 5, Iss C, Pp 106-115 (2017)
Intravenous administration of adeno-associated virus serotype 9 (AAV9)/hMECP2 has been shown to extend the lifespan of Mecp2−/y mice, but this delivery route induces liver toxicity in wild-type (WT) mice. To reduce peripheral transgene expression,
Externí odkaz:
https://doaj.org/article/4e66309230e84338a6ba9fd000c7402a
Publikováno v:
Developmental neuroscience. 43(3-4)
Neurodevelopmental disorders (NDDs) include a broad spectrum of disorders that disrupt normal brain development. Though some NDDs are caused by acquired insults (i.e., toxic or infectious encephalopathy) or may be cryptogenic, many NDDs are caused by
Publikováno v:
Brain
MECP2 gene transfer has been shown to extend the survival of Mecp2−/y knockout mice modelling Rett syndrome, an X-linked neurodevelopmental disorder. However, controlling deleterious overexpression of MECP2 remains the critical unmet obstacle towar
Autor:
Ahamed Hossain, Quiang Chang, Michela Fagiolini, Shilpa D. Kadam, Annarita Patrizi, Steven J. Gray, Jocelyn LeBlanc, Lee-Way Jin, Huda Y. Zoghbi, Zhaolan Zhou, Michael V. Johnston, Sakkubai Naidu, Xinyu Zhao, Mary E. Blue, Sarah E. Sinnett, John J. Foxe, Sophie Molholm, Izumi Maezawa
Publikováno v:
Neuroscience
Disruptions in the gene encoding methyl-CpG binding protein 2 (MECP2) underlie complex neurodevelopmental disorders including Rett Syndrome (RTT), MECP2 duplication disorder, intellectual disabilities, and autism. Significant progress has been made o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31003a729579a8717a7f0ab25a522df3
https://europepmc.org/articles/PMC8025698/
https://europepmc.org/articles/PMC8025698/
Gene therapy has become a promising strategy to treat the genetic disorders of central nervous system (CNS). In the last five decades the development and characterization of recombinant adeno-associated virus (rAAV) as a safe and effective vector for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a9ed6f8eaa2bc932c39d778c9da39236
https://doi.org/10.1016/b978-0-12-813955-4.00010-6
https://doi.org/10.1016/b978-0-12-813955-4.00010-6
Autor:
Nicholas Ah Mew, Wado Akamatsu, Hasan Orhan Akman, Afnan AlHakeem, Koji Aoyama, Rafael Artuch, Michael Beck, C. Frank Bennett, Gerard T. Berry, D. Montgomery Bissell, Brenda Canine, C. Thomas Caskey, Widler Casy, Patrick F. Chinnery, David T. Chuang, Emily K. Cook, Rody P. Cox, Philip L. De Jager, Didem Demirbas, Robert J. Desnick, Salvatore DiMauro, Florian S. Eichler, Bernice Elger, Valentina Emmanuele, Patricia Evans, Brent L. Fogel, Àngels García-Cazorla, Cinzia Gellera, Sailaja Golla, Kimberly Goodspeed, Sidney M. Gospe, Steven J. Gray, Andrea L. Gropman, Yian Gu, Renzo Guerrini, Teresa M. Gunn, Una Hadziahmetovic, Darrah Haffner, R.J. Hagerman, Tamar Harel, Elizabeth Head, Rita Horvath, Yasushi Hosoi, Ying-Chen Claire Hou, Jane Hsiao, Hiroyuki Ishiura, Clifford R. Jack, Vikram Jakkamsetti, William G. Johnson†, Fabrice Jotterand, John P. Kane, Olga Khorkova, Chisato Kinoshita, Sanne E. Klompe, Lisa M. Koehl, Michael C. Kruer, Walter A. Kukull, Roger M. Lane, Joseph H. Lee, M.J. Leigh, Qinglan Ling, James R. Lupski, Paola Luzi, Qian Ma, Gustavo H.B. Maegawa, Mary J. Malloy, Seth S. Margolis, Isaac Marin-Valencia, James A. Mastrianni, Dena Matalon, Reuben Matalon, Kimberlee Michals Matalon Rd, Jennifer M. Mathews, Richard Mayeux, Jennifer McCurdy, Meira R. Meltzer, John H. Menkes†, Justin Miron, Jun Mitsui, Hiroaki Miyajima, Lisa M. Monteggia, Mary Ann Morris, Hugo W. Moser†, Melissa E. Murray, Toshio Nakaki, Nathalie Nilsson, Ichizo Nishino, Sandra M.H. Nordlie, Robert L. Nussbaum, William L. Nyhan, Hideyuki Okano, Sergio Padilla-Lopez, Elena Parrini, Juan M. Pascual, Gregory M. Pastores, Shailendra B. Patel, Marc C. Patterson, Izabella A. Pena, Cynthia Picard, Judes Poirier, Jennifer E. Posey, Gerald V. Raymond, William Renthal, David S. Rosenblatt, Francis Rossignol, Gerald Salen, Konrad Sandhoff, Raphael Schiffmann, Detlev Schindler, Frederick A. Schmitt, Susanne A. Schneider, Eric A. Schon, Edward H. Schuchman, Margretta Reed Seashore, Frances C. Shaffo, Michael Shevell, Sarah E. Sinnett, Myriam Srour, Samuel H. Sternberg, Kazuma Sugie, Kristen L. Szabla, Franco Taroni, Marina Tedeschi Dauar, Shoji Tsuji, Wendy R. Uhlmann, Clara van Karnebeek, Kathryn L. Van Pelt, Prashanthi Vemuri, Charles P. Venditti, Claes Wahlestedt, Bruce Wang, David Watkins, David A. Wenger, Charles A. Williams, Golder N. Wilson, Barry Wolf, R. Max Wynn, Hung-Chun Yu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::57d33606a0dd70f9459d3237b2c69dcb
https://doi.org/10.1016/b978-0-12-813955-4.00079-9
https://doi.org/10.1016/b978-0-12-813955-4.00079-9
Autor:
Sarah E, Sinnett, Steven J, Gray
Publikováno v:
Discovery medicine. 24(132)
Rett Syndrome (RTT) is an X chromosome-linked neurodevelopmental disorder caused by inactivating mutations in the transcription regulator methyl CpG-binding protein 2 (MeCP2). Multiple studies have independently explored the therapeutic potential of
Autor:
Stuart Cobb, Steven J. Gray, Noha Gamal Bahey, Ralph D. Hector, Kamal K.E. Gadalla, Mark E.S. Bailey, Sarah E. Sinnett, Thishnapha Vudhironarit
Publikováno v:
Gadalla, K K E, Vudhironarit, T, Hector, R D, Sinnett, S, Bahey, N G, Bailey, M E S, Gray, S J & Cobb, S R 2017, ' Development of a novel AAV gene therapy cassette with improved safety features and efficacy in a mouse model of Rett syndrome ', Molecular Therapy-Methods and Clinical Development, vol. 5, pp. 180-190 . https://doi.org/10.1016/j.omtm.2017.04.007
Molecular Therapy: Methods & Clinical Development, Vol 5, Iss C, Pp 180-190 (2017)
Molecular Therapy. Methods & Clinical Development
Molecular Therapy: Methods & Clinical Development, Vol 5, Iss C, Pp 180-190 (2017)
Molecular Therapy. Methods & Clinical Development
Rett syndrome (RTT), caused by loss-of-function mutations in the MECP2 gene, is a neurological disorder characterized by severe impairment of motor and cognitive functions. The aim of this study was to investigate the impact of vector design, dosage,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c91bb44473509457d3ceef8795540ab1
https://hdl.handle.net/20.500.11820/59056b4e-4568-4bbc-b2e6-657b3198bc0c
https://hdl.handle.net/20.500.11820/59056b4e-4568-4bbc-b2e6-657b3198bc0c
Autor:
Mark E.S. Bailey, Steven J. Gray, Clifford Heindel, Daphne Chen, Kamal K.E. Gadalla, Violeta Zaric, Sarah E. Sinnett, Ralph D. Hector, Stuart Cobb
Publikováno v:
Sinnett, S E, Hector, R D, Gadalla, K K E, Heindel, C, Chen, D, Zaric, V, Bailey, M E S, Cobb, S R & Gray, S J 2017, ' Improved MECP2 gene therapy extends the survival of MeCP2-null mice without apparent toxicity after intracisternal delivery ', Molecular Therapy-Methods and Clinical Development, vol. 5, pp. 106-115 . https://doi.org/10.1016/j.omtm.2017.04.006
Molecular Therapy: Methods & Clinical Development, Vol 5, Iss C, Pp 106-115 (2017)
Molecular Therapy: Methods & Clinical Development, Vol 5, Iss C, Pp 106-115 (2017)
Intravenous administration of adeno-associated virus serotype 9 (AAV9)/ hMECP2 has been shown to extend the lifespan of Mecp2 −/y mice, but this delivery route induces liver toxicity in wild-type (WT) mice. To reduce peripheral transgene expression
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::534f62ede21a1ed4b095c8c9075d3775
https://eprints.gla.ac.uk/139919/7/139919.pdf
https://eprints.gla.ac.uk/139919/7/139919.pdf
Autor:
Sarah E, Sinnett, Ralph D, Hector, Kamal K E, Gadalla, Clifford, Heindel, Daphne, Chen, Violeta, Zaric, Mark E S, Bailey, Stuart R, Cobb, Steven J, Gray
Publikováno v:
Molecular Therapy. Methods & Clinical Development
Intravenous administration of adeno-associated virus serotype 9 (AAV9)/hMECP2 has been shown to extend the lifespan of Mecp2−/y mice, but this delivery route induces liver toxicity in wild-type (WT) mice. To reduce peripheral transgene expression,